DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how ...

Narrow-moat Icon is continuing to work through a challenging macroeconomic environment, as some of its customers are undergoing budget cuts and reprioritizations of their pipeline candidates. However, ...

Icon PLC (ICLR) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Icon ( (ICLR)) has issued an announcement ...

Icon ICLR reported strong fourth-quarter results highlighted by revenue of $1.9 billion, representing an increase of 4% from the prior-year period. Full-year revenue of $7.7 billion represented an ...

Stock-based compensation expense represents the amount of recurring expense related to the company’s equity compensation programs (inclusive of employer related taxes). (b) Foreign currency ...

Icon Plc ( (ICLR)) has released its Q3 earnings. Here is a breakdown of the information Icon Plc presented to its investors. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its ICON Cares 2023 Report. This outlines how the company is ...